抗脂抗体与老年人死后脑梗塞的关系

Zoe Arvanitakis1, Robin L Brey2, Jacob H Rand2

  • 1From the Rush Alzheimer's Disease Center (Z.A., J.A.S., A.W.C., L.Y., S.E.L., D.A.B.), Department of Neurological Sciences (Z.A., J.A.S., A.W.C., L.Y., S.E.L., D.A.B.), and Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio (R.L.B.); Department of Pathology, Montefiore Medical Center, Bronx, NY (J.H.R.); and Departments of Neurology and Emergency Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, and Department of Neurology, Kings County Hospital Center, Brooklyn, NY (S.R.L.). zarvanit@rush.edu.

Circulation
|October 11, 2014
PubMed
概括

抗脂抗体 (aPLs) 与老年人脑梗塞风险增加无关. 这项研究没有发现证据表明aPLs与接受尸检的社区居民的病理性脑梗塞有关.